6
H index
4
i10 index
141
Citations
Johann Matthias Graf von der Schulenburg : Citation Profile
Leibniz Universität Hannover | RESEARCH PRODUCTION: 38 Articles 3 Papers EDITOR: RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
32 years (1991 - 2023). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Johann Matthias Graf von der Schulenburg. | Is cited by:
| Cites to:
|
Main data
Where Johann Matthias Graf von der Schulenburg has published?
| Journals with more than one article published | # docs |
|---|---|
| The European Journal of Health Economics | 12 |
| Health Economics Review | 10 |
| The Geneva Papers on Risk and Insurance - Issues and Practice | 5 |
| Health Policy | 3 |
| The Geneva Risk and Insurance Review | 3 |
Recent works citing Johann Matthias Graf von der Schulenburg (2024 and 2023)
| Year | Title of citing document | |
|---|---|---|
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | Survival analysis of cancer patients in Portugal following the reference centre model implementation. (2023). Portugal, Rui ; Catalo-Lopes, Margarida ; Mateus, Manuel Melo. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01461-x. Full description at Econpapers || Download paper | |
| 2023 | EQ-5D-5L: a value set for Romania. (2023). Vale, Luke ; Paveliu, Marian Sorin ; Niculescu-Aron, Ileana Gabriela ; Caplescu, Raluca ; Oluboyede, Yemi ; Mohammed, Wael ; Olariu, Elena. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01481-7. Full description at Econpapers || Download paper | |
| 2023 | Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4. Full description at Econpapers || Download paper | |
| 2023 | Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders. (2023). Gallinat, Jurgen ; Keetharuth, Anju Devianee ; Konig, Hans-Helmut ; Grochtdreis, Thomas ; Dams, Judith ; Karow, Anne ; Lambert, Martin ; Schulz, Holger ; Konnopka, Alexander. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01489-z. Full description at Econpapers || Download p | |
| 2023 | Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0. Full description at Econpapers || Download paper | |
| 2023 | Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks. (2023). Brouwer, Werner ; Exel, Job ; Himmler, Sebastian ; Perry-Duxbury, Meg. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01527-w. Full description at Econpapers || Download paper | |
| 2023 | The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. (2023). Drummond, Michael ; Nicod, Elena ; Meregaglia, Michela. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01541-y. Full description at Econpapers || Download paper | |
| 2023 | Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D. (2023). Albus, Christian ; Weber, Cora ; Stolz, Maike ; Sollner, Wolfgang ; Schultz, Jobst-Hendrik ; Ronel, Joram ; Petrowski, Katja ; Michal, Matthias ; Herrmann-Lingen, Christoph ; Fritzsche, Kurt ; Deter, Hans-Christian ; Krauth, Christian ; Beutel, Manfred E ; Zwaan, Martina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01543-w. Full description at Econpapers || Download 2023 | Diffusion of a new drug among ambulatory physicians—The impact of patient pathways. (2023). Sundmacher, Leonie ; Donnerbanzhoff, Norbert ; Frolich, Franziska ; Flemming, Ronja. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:4:p:970-982. Full description at Econpapers || Download paper |
Johann Matthias Graf von der Schulenburg is editor of
| Journal | |
|---|---|
| Health Economics Review |
Johann Matthias Graf von der Schulenburg has edited the books:
| Year | Title | Type | Cited |
|---|
Works by Johann Matthias Graf von der Schulenburg:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2014 | Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftig In: Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften. [Full Text][Citation analysis] | article | 0 |
| 2012 | Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study In: Health Policy. [Full Text][Citation analysis] | article | 6 |
| 2022 | Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments In: Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2002 | Diffusion of innovations: treatment of Alzheimers disease in Germany In: Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2015 | Cost of poor adherence to anti-hypertensive therapy in five European countries In: Post-Print. [Citation analysis] | paper | 3 |
| 2014 | Grundlagen und Methoden von GKV-Routinedatenstudien In: Hannover Economic Papers (HEP). [Full Text][Citation analysis] | paper | 3 |
| 2007 | Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? In: Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik). [Full Text][Citation analysis] | article | 0 |
| 1991 | Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 19 |
| 2009 | Reinsurance Brokers and Advice Quality: Is There a Need for Regulation? In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 2 |
| 2012 | Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 3 |
| 2010 | On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 3 |
| 2010 | Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need* In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 8 |
| 2017 | An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 0 |
| 2019 | Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 0 |
| 2020 | Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 1 |
| 2013 | Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe In: CEIS Research Paper. [Full Text][Citation analysis] | paper | 0 |
| 2016 | Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2010 | Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2010 | EJHE has an official impact factor of 1.337 In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2011 | Letter from the editors In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2015 | Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2016 | Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 15 |
| 2020 | HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2021 | COVID-19: not the time for health economists? A plea for more proactive health economic involvement In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2002 | Commentary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2005 | Validating the EQ-5D with time trade off for the German population In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 20 |
| 2005 | German health care system in transition In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2005 | Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2007 | Editor’s note In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2011 | Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers In: Health Economics Review. [Full Text][Citation analysis] | article | 4 |
| 2011 | Greetings from the Editors In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2011 | Promoting vaccinations - an analysis of measures taken by German statutory health insurers In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2012 | Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany In: Health Economics Review. [Full Text][Citation analysis] | article | 4 |
| 2013 | Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2015 | Regional differences in health care of patients with inflammatory bowel disease in Germany In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2015 | Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - In: Health Economics Review. [Full Text][Citation analysis] | article | 1 |
| 2016 | Benefit assessment in Germany: implications for price discounts In: Health Economics Review. [Full Text][Citation analysis] | article | 3 |
| 2016 | Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks In: Health Economics Review. [Full Text][Citation analysis] | article | 3 |
| 2018 | “Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations In: Health Economics Review. [Full Text][Citation analysis] | article | 1 |
| 2018 | German Value Set for the EQ-5D-5L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 18 |
| 2023 | Digital Transformation in Back-Offices of German Insurance Companies In: International Journal of Innovation and Technology Management (IJITM). [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team